Hey,
We've posted new content on stem cell and cord blood markets that I'm excited to share it with you. Let me know what you think.
[Just Released] "Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report"
Recent months have seen the first iPSC trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting iPSC rights, announcement of an iPSC therapy clinic scheduled to open in 2019, and more. iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends indicate what may happen in 2015 and beyond. Are you informed about rapidly-evolving market conditions and able to identify key market trends before your competition? [Click to continue...]
When assessing a specific cell type, such as induced pluripotent stem cells, the “United State Patent and Trademark Office Full-Text and Image Database" database provides crucial information for several business intelligence (BI) metrics of importance, including dominant industry players, patent trend rates, geographical clustering of patent assignees, frequency of specific patent types, and more. [Click to continue...]
More posts on stem cells:
More posts on cord blood:
Enjoy the content and let me know what else you'd like to see covered!
Cade
President/CEO of BioInformant Stem Cell Research Firm
p.s. If you're interested in partnering for stem cell or cord blood related opportunities, you can reach me by replying to this email. |
|
|
